Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 18, 1997

View Archived Issues

Ferring permitted to resume marketing of Repronex

PharmaPrint submits IND for herbal BPH treatment

Astra: 1997 half-year highlights

Terrapin and Taiho sign development agreement for anticancer agent

New biotech company formed to combat cardiovascular diseases

FDA proposes to require pediatric data on drugs

U.S. patent issued for Candida albicans treatment method

Spanish scientists discover anxiolytic CCKA antagonist

Phase I trial of DiffGAM completed successfully

Sequana, Boehringer Mannheim closer to elucidating genetic basis of osteoporosis

Vasopressin agonist from Otsuka

Phenobarbital ineffective in stopping brain bleeding in neonates

Twinrix now available for pediatric use

Novo Nordisk: 1997 half-year highlights

GalaGen starts Diffistat-G phase II trial

VEGF RTK inhibitors in the pipeline at Zeneca

Clinical trial results announced for novel incontinence therapeutic

New treatment for osteoarthritis approved for marketing in U.S.

Patents for collagen markers issued to Ostex

Drug discovery agreement forged by Procept, Abbott

Onyx, W-L collaborate on antiinflammatory and immunomodulating agents

SmithKline Beecham donates Havrix vaccine to flood areas

Glaxo Wellcome discloses a new series of thrombin inhibitors

Sporidin-G trial put on hold

IRIS licenses patents to TOA

Delmopinol inhibits gingivitis in extreme rates of plaque formation

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 26, 2026.
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
Emerging therapeutic strategies for Parkinson’s at ADPD 2026
BioWorld
Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 24, 2026